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Doença Celíaca 
• Considerada a doença mais subdiagnosticada nos EUA.  
• Afecta ~1/100 pessoas., Só nos EUA há mais de 1 milhão de pessoas 
com D. Celíaca 
• Os doentes têm sintomas durante anos sem serem diagnosticados, 
demorando em média 8 anos até ao diagnóstico. 
• Os doentes não diagnosticados estão predispostos para osteoporose, 
têm anemia e desconforto gastrointestinal crónico, com atraso de 
desenvolvimentop e de aprendizagem nas crianças  e cancros 
linfáticos. 
• Chamada “enteropatia sensível ao glúten”.   
• Ocorre como consequência de ingestão de grão que contém glúten tal 
como o trigo, cevada, centeio, aveia, kamut, espelta, bulgur. 
 
Pathogenesis: 
1. A component of gluten, gliaden, 
interacts with a specific genetic form of 
HLA receptor on an antigen presenting 
cell. 
 
2. Tissue transglutaminase converts 
glutamine residues to glutamic acid 
residues making an even more potent 
antigen. 
 
3. T helper cells are activated and, in 
turn, activate B and killer T cells. 
 
4. Plasma cell antibodies bind to 
gliadin bound to enterocytes, tissue 
transglutaminase and reticular fibers 
surrounding gut smooth muscle 
(endomysial ab’s). 
 
5. T cells release (inappropriate) 
inflammatory cytokines as well as 
inflict tissue damage. 
 
Source:NEJM 346:180, 2002 
 
Celiac disease (CD) 
• It is an immune-mediated disease of the intestines that is triggered by the ingestion of 
gluten in genetically susceptible individuals. Gluten is the major protein component of 
wheat, rye, and barley. 
 
• Inflammation resulting from immune system overactivity may cause a wide variety of 
signs and symptoms involving many parts of the body. 
 
• Celiac disease can develop at any age 
 
• The classic symptoms result from inflammation affecting the gastrointestinal tract, 
that damages the villi, reducing the surface area to absorb nutrients.  
 
• The villi become shortened and eventually flatten out.  
• Intestinal damage causes diarrhea and poor absorption of nutrients, which may lead 
to weight loss.  
• Abdominal pain, swelling (distention), and food intolerances are common. 
 
• Inflammation may lead to an increased risk of developing certain gastrointestinal 
cancers such as cancers of the small intestine or esophagus. 
•   
 
Normal intestinal biopsy 
Small intestinal biopsy 
in a patient with active 
celiac disease  
Source:NEJM 
Celiac disease (CD) 
• Iron deficiency (anemia), vitamin deficiencies, osteoporosis, 
dermatitis herpetiformis, defects in the enamel of the teeth, 
chronic fatigue, joint pain, poor growth, delayed puberty, 
infertility, or repeated miscarriages.  
 
• Neurological problems have also been associated with celiac 
disease; these include migraine headaches, depression, attention 
deficit hyperactivity disorder (ADHD), and recurrent seizures 
(epilepsy).  
 
• Many people with celiac disease have one or more of these varied 
health problems but do not have gastrointestinal symptoms. This form 
of the condition is called nonclassic celiac disease.  
 
• Researchers now believe that nonclassic celiac disease is actually 
more common than the classic form. 
Normal intestinal surgical 
specimen with distinct villi  
Celiac disease specimen with 
total loss of villi, the arrows 
indicate crypt openings Source: Pathology of the Gastrointestinal Tract, 2nd Ed., 
1998, Ed. by Ming and Goldman 
, 
Genetic predisposition  to CD 
• Genetic predisposition plays a key role in CD and considerable 
progress has been made recently in identifying genes that are 
responsible for CD predisposition.   
• CD is strongly associated with specific HLA class II genes HLA-
DQ2 and HLA-DQ8 located on chromosome 6p21. 
 
• Approximately 95% of CD patients express HLA-DQ2, and the 
remaining patients are usually HLA-DQ8 positive. 
 
• The  HLA-DQ2 allele is common and is carried by approximately 
30% of Caucasian individuals.  
 
• Thus, HLA-DQ2 or HLA-DQ8 is necessary for disease development 
but is not sufficient for disease development;  
 
• Its estimated risk effect is only 36-53%. 
 
 
Celiac disease risk loci  
• Trynka et al comprehensively surveyed the genetic architecture of all 
known risk loci previously associated with immune-mediated diseases 
in 12,041 patients with celiac disease and 12,228 controls. They 
identified 13 new celiac disease risk loci reaching genome-wide 
significance, some being present in single genes or regulatory 
genes. Even if each of the identified genes have little "weight" in 
defining a celiac disease genetic trait, they add to the growing pieces 
(now approximately 40 genes) of the celiac disease genetic puzzle.[3] 
 
• Guidelines for CD diagnosis from the European Society for Paediatric 
Gastroenterology, Hepatology, and Nutrition (ESPGHAN) propose the 
option to omit the duodenal biopsy in the diagnosis of CD if all 4 of 
the following criteria are met in children and adolescents[4, 5, 6, 7] : 
 
 
•  Ref - emedicine.medscape.com/article/1790189-overview 
To omit the duodenal biopsy in the diagnosis of CD 




• Signs and symptoms suggestive of CD 
 
• Anti-transglutaminase type 2 antibody (anti-TG2) levels more 
than 10 times the upper limit of normal 
 
• Positive confirmation tests of anti-endomysium-IgA 
antibodies (EMA) 
 





   Ref - emedicine.medscape.com/article/1790189-overview 
Arrows indicate intraepithelial lymphocytes which, in 
this disease, are destructive. 
Arrowheads indicate plasma cells which are secreting ab’s against 
gliaden bound to enterocytes as well against reticulin and tissue 
transglutaminase resulting in tissue destruction. Source:NEJM 
HLA-DQ2 and DQ8 alleles 
 
• About 95% of people with celiac disease have the HLA-DQ2 allele and 
most of the remaining 5% have the HLA-DQ8 allele.  
 
• Having the alleles means you are at risk for developing celiac 
disease, but does not mean that you definitely have the disease.  
 
• A positive genetic test should be followed up with a celiac blood panel 
to determine if you have celiac disease.  
 






HLA DR3–DQ2 or HLA DR4–DQ8  
 
• The presence of HLA haplotype DR3–DQ2 or DR4–DQ8 is associated 
with an increased risk of celiac disease.  
 
• In addition, nearly all children with celiac disease have serum 
antibodies against tissue transglutaminase (tTG).  
 
• Children with the HLA haplotype DR3–DQ2, especially 
homozygotes, were found to be at high risk for celiac disease early 
in childhood.  
 
• The higher risk in Sweden than in other countries highlights the 
importance of studying environmental factors associated with celiac 
disease. 
Others autoimmune diseases 
 
• Having an autoimmune disorder makes you 
more likely to develop other autoimmune 
diseases, like celiac disease.  
 
• Thyroid disease, Type 1 diabetes mellitus, 
primary biliary cirrhosis, etc... 
Treatment 
• There is only one treatment, strict adherence to a gluten-
free diet. 
• Gluten-free foods are limited, and frequently unavailable. 
• Gluten-free foods cost 2-3X that of normal foods. 
• Unfortunately, purchase of gluten-free products is rarely 
covered by health insurance. 
• The good news is that strict adherence to a gluten-free diet 
can have an extraordinary outcome as seen on the next slide. 
• Source:www.glutin.net 
When the patient adheres to a strict gluten-free diet, the damaged intestinal 
mucosa (often but not always ) completely regenerates including reformation 





As the damage recedes, the ragged, lymphocyte infiltrated-enterocytes 
are replaced by normal columnar ones, thus assuring normal transport 
from the lumen into the body. 
Source:NEJM 
Alimentos sem glúten 
• Arroz e milho 
• Quinoa 
• Millet (panicum miliaceum) 
• Amaranto (Amaranthus hypochondriacus) 
• Trigo sarraceno (Fagopyrum esculentum) 
• Sorgo (Sorghum) 
• Flocos de batata, tapioca, farinha de amêndoa, avelã, noz, ... 
(só precisa de triturar os frutos ao natural) 




• Newly identified genetic risk variants for celiac disease related to 
the immune response 
Nature Genetics 40, 395 - 402 (2008)  
 
– Type 1 diabetes and celiac disease share HLA-DQ, IL2–IL21, CCR3 andSH2B3 risk 
regions. Thus, this extensive genome-wide association follow-up study has 
identified additional celiac disease risk variants in relevant biological pathways. 
 
 
• Detecting shared pathogenesis from the shared genetics of 
immune-related diseases 
Nature Reviews Genetics 10, 43-55 (January 2009) |  
– Recent genetic studies have revealed shared immunological mechanisms in several 
immune-related disorders  
HLA DQ 
• HLA class II region  
   (either DQ2 [DQA*0501-DQB*0201] 
     or    DQ8 [DQA*0301-DQB1*0302]) 
confer a large part of the genetic 
susceptibility to celiac disease.  
 
• Celiac disease originates as a result of a 
combined action involving both adaptive 
and innate immunity. 
  
• Anti-endomysium-IgA antibodies 
(EMA)  
• Teste de imunofluorescência com esófago de macaco 
 
• Anti-transglutaminase type 2 antibody 
(anti-TG2)      
• Teste ELISA  
Spectrum of gluten-related disorders: consensus 
on new nomenclature and classification 
 Sapone et al. BMC Medicine 2012, 10:13 
• The toxic protein fractions of gluten include gliadins and glutenins, with 
gliadins containing monomeric proteins and glutenins containing aggregated 
proteins 
 
• 3 main forms of gluten reactions:  
– allergic (wheat allergy),  
– autoimmune (celiac disease, dermatitis herpetiformis and gluten ataxia) and  
– possibly immune-mediated (gluten sensitivity) 
 
• Mediated by the adaptive immune system: wheat allergy (WA) and celiac disease (CD).  
• In both conditions the reaction to gluten is mediated by T-cell activation in the gastrointestinal mucosa. 
•   
• However, in WA it is the cross-linking of immunoglobulin (Ig)E by repeat sequences in gluten 
peptides (for example, serine-glutamine-glutamine -glutamine-( glutamine-)proline-proline-
phenylalanine) that triggers the release of chemical mediators, such as histamine, from basophils 
and mast cells [1].  
• In contrast, CD is an autoimmune disorder, as demonstrated by specific serologic autoantibodies, 
most notably serum anti-tissue transglutaminase (tTG) and anti-endomysial antibodies (EMA). 
Spectrum of gluten-related disorders: consensus 
on new nomenclature and classification 
 Sapone et al. BMC Medicine 2012, 10:13 
